What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Diabetes mellitus
His primary scientific interests are in Internal medicine, Weight loss, Endocrinology, Obesity and Surgery.
His research on Internal medicine often connects related areas such as Gastroenterology.
His Weight loss study combines topics from a wide range of disciplines, such as Taste, Randomized controlled trial, Systemic inflammation and Bile acid.
Endocrinology is closely attributed to Peptide YY in his research.
The study incorporates disciplines such as Microbiome, Bioinformatics, Energy expenditure and Disease in addition to Obesity.
His biological study spans a wide range of topics, including Gastrectomy, MEDLINE, Malabsorption, Blood pressure and Type 2 diabetes.
His most cited work include:
- Inhibition of food intake in obese subjects by peptide YY3-36. (1388 citations)
- Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters (826 citations)
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (733 citations)
What are the main themes of his work throughout his whole career to date?
Carel W. le Roux mostly deals with Internal medicine, Weight loss, Surgery, Obesity and Endocrinology.
His Internal medicine study integrates concerns from other disciplines, such as Diabetes mellitus, Type 2 diabetes and Gastroenterology.
His Weight loss research incorporates elements of Body mass index, Malabsorption, Meal and Intensive care medicine.
The Surgery study combines topics in areas such as Metabolic surgery, Sleeve gastrectomy, Glycemic and Insulin resistance.
His Obesity study incorporates themes from Liraglutide, Disease, Type 2 Diabetes Mellitus and Prediabetes.
As a part of the same scientific study, Carel W. le Roux usually deals with the Endocrinology, concentrating on Peptide YY and frequently concerns with Ghrelin.
He most often published in these fields:
- Internal medicine (85.06%)
- Weight loss (66.53%)
- Surgery (62.15%)
What were the highlights of his more recent work (between 2019-2021)?
- Obesity (61.16%)
- Type 2 diabetes (41.43%)
- Surgery (62.15%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Obesity, Type 2 diabetes, Surgery, Internal medicine and Weight loss.
In Obesity, Carel W. le Roux works on issues like Prospective cohort study, which are connected to Canagliflozin.
His studies deal with areas such as Placebo, Albuminuria, Kidney disease and Glycemic as well as Type 2 diabetes.
His study in Surgery is interdisciplinary in nature, drawing from both Body mass index, Sleeve gastrectomy and Insulin resistance.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Prediabetes.
His Weight loss research is multidisciplinary, relying on both Liraglutide, Hormone, Ghrelin, Carbohydrate metabolism and Appetite.
Between 2019 and 2021, his most popular works were:
- Joint international consensus statement for ending stigma of obesity. (90 citations)
- Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery. (61 citations)
- Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial. (23 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Surgery
Carel W. le Roux focuses on Obesity, Internal medicine, Surgery, Weight loss and Type 2 diabetes.
Carel W. le Roux combines subjects such as Observational study and Environmental health with his study of Obesity.
His Internal medicine research focuses on subjects like Endocrinology, which are linked to Peptide YY.
His study looks at the relationship between Surgery and topics such as Sleeve gastrectomy, which overlap with Meal.
His work in Weight loss covers topics such as Ghrelin which are related to areas like Gastroenterology, Glucose homeostasis and Roux-en-Y anastomosis.
The concepts of his Type 2 diabetes study are interwoven with issues in Placebo and Albuminuria, Kidney disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
